Maike Nortmeyer
Publications by Year
Research Areas
Protein Degradation and Inhibitors, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Neuroblastoma Research and Treatments, Chromatin Remodeling and Cancer
Most-Cited Works
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies(2014)146 cited
- → GSEA general cell biology gene sets from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Data from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Supplementary Figure 5. from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → MYCN targets OTX015_BRD4 and gene expression from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → All genes Hg19_BRD4_OTX from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Supplementary Figure 1. from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Supplementary Figure 3. from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)